Literature DB >> 31908049

Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection.

Jin-Lei Wang1, Meng-Jie Bai1, Hany M Elsheikha2, Qin-Li Liang1, Ting-Ting Li1, Xue-Zhen Cao3, Xing-Quan Zhu1.   

Abstract

Dense granule protein 12 (GRA12) is implicated in a range of processes related to the establishment of Toxoplasma gondii infection, such as the formation of the intravacuolar network (IVN) within the parasitophorous vacuole (PV). This protein is also thought to be important for T. gondii-host interaction, pathogenesis, and immune evasion, but their exact roles remain unknown. In this study, the contributions of GRA12 to the molecular pathogenesis of T. gondii infection were examined in vitro and in vivo. Deletion of GRA12 in type I RH and type II Pru T. gondii strains did not affect the parasite growth and replication in vitro, however, it caused a significant reduction in the parasite virulence and tissue cyst burden in vivo. T. gondii Δgra12 mutants were more vulnerable to be eliminated by host immunity, without the accumulation of immunity-related GTPase a6 (Irga6) onto the PV membrane. The ultrastructure of IVN in Δgra12 mutants appeared normal, suggesting that GRA12 is not required for biogenesis of the IVN. Combined deletion of GRA12 and ROP18 induced more severe attenuation of virulence compared to single Δgra12 or Δrop18 mutant strains. These data suggest a functional association between GRA12 and ROP18 that is revealed by the severe attenuation of virulence in a double mutant relative to the single individual mutations. Future studies are needed to define the molecular basis of this putative association. Collectively these findings indicate that although GRA12 is not essential for the parasite growth and replication in vitro, it contributes to the virulence and growth of T. gondii in mice.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  zzm321990Toxoplasma gondiizzm321990; dense granule protein 12; immunity-related GTPases; intravacuolar network; rhoptry protein 18; virulence

Mesh:

Substances:

Year:  2020        PMID: 31908049     DOI: 10.1096/fj.201901416RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  In vitro Effect of Harmine Alkaloid and Its N-Methyl Derivatives Against Toxoplasma gondii.

Authors:  Maria L Alomar; Juan G Yañuk; Sergio O Angel; M Micaela Gonzalez; Franco M Cabrerizo
Journal:  Front Microbiol       Date:  2021-08-05       Impact factor: 6.064

Review 2.  Unifying Virulence Evaluation in Toxoplasma gondii: A Timely Task.

Authors:  Rafael Calero-Bernal; Mercedes Fernández-Escobar; Frank Katzer; Chunlei Su; Luis Miguel Ortega-Mora
Journal:  Front Cell Infect Microbiol       Date:  2022-04-28       Impact factor: 6.073

Review 3.  Seizing control: How dense granule effector proteins enable Toxoplasma to take charge.

Authors:  Michael W Panas; John C Boothroyd
Journal:  Mol Microbiol       Date:  2021-02-06       Impact factor: 3.501

4.  iTRAQ-Based Phosphoproteomic Analysis of Toxoplasma gondii Tachyzoites Provides Insight Into the Role of Phosphorylation for its Invasion and Egress.

Authors:  Cheng He; Mei-Zhen Xu; Shuai Pan; Hui Wang; Hong-Juan Peng; Zhuan-Zhuan Liu
Journal:  Front Cell Infect Microbiol       Date:  2020-11-26       Impact factor: 5.293

5.  Anti-infection roles of miR-155-5p packaged in exosomes secreted by dendritic cells infected with Toxoplasma gondii.

Authors:  Dan Jiang; Shuizhen Wu; Liqing Xu; Guantai Xie; Dongliang Li; Hongjuan Peng
Journal:  Parasit Vectors       Date:  2022-01-06       Impact factor: 3.876

6.  Functional Characterization of 17 Protein Serine/Threonine Phosphatases in Toxoplasma gondii Using CRISPR-Cas9 System.

Authors:  Qin-Li Liang; Lan-Bi Nie; Ting-Ting Li; Hany M Elsheikha; Li-Xiu Sun; Zhi-Wei Zhang; Dan-Yu Zhao; Xing-Quan Zhu; Jin-Lei Wang
Journal:  Front Cell Dev Biol       Date:  2022-01-10

Review 7.  Secreted Effectors Modulating Immune Responses to Toxoplasma gondii.

Authors:  Tadakimi Tomita; Rebekah B Guevara; Lamisha M Shah; Andrews Y Afrifa; Louis M Weiss
Journal:  Life (Basel)       Date:  2021-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.